Company Data
Moleculin Biotech Inc.
Ticker
MBRX
Current Price
$2.1 -3.23%
Market Cap
$11.2M
Price Target
Refer to Report
Volume
152.1K
52wk Range
$1.79 - $24
Overview
Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis.